Targeting the translation machinery in cancer

Dysregulation of mRNA translation is a frequent occurrence in cancer cells, and several components of the translation machinery have emerged as promising targets for anticancer therapeutics. This Review discusses the mechanisms of aberrant mRNA translation in cancer cells and provides an overview of drugs in development that target the translation machinery.